Cancer Research Institute, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Biomedical Research Institute, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, 03080, Seoul, Republic of Korea.
BMC Cancer. 2023 Sep 6;23(1):831. doi: 10.1186/s12885-023-11185-7.
Heterogeneous tumor cells are thought to be a significant factor in the failure of endocrine therapy in estrogen receptor-positive (ER+) cancers. Culturing patient-derived breast cancer cells (PDBCCs) provides an invaluable tool in pre-clinical and translational research for the heterogeneity of cancer cells. This study aimed to investigate the effects of different media components and culture methods on the BCSC-associated immunophenotypes and gene expression in ER + PDBCCs.
Ten patients with ER + breast cancer were employed in this study, six of whom had neoadjuvant chemotherapy and four of whom did not. PDBCCs were isolated by enzymatic methods using collagen I and hyaluronidase. PDBCCs were grown as monolayers in mediums with different compositions and as multicellular spheroid in a suspended condition. Collagen I-coated plate and ultralow attachment plate coated with polymer-X were used for monolayer and spheroid culture. Flow cytometry, immunofluorescent staining, RT-PCR, and RNA-sequencing were employed to examine the immunophenotype and genetic profile of PDBCCs.
More than 95% of PDBCCs sustain EpCAM high/+/fibroblast marker- phenotypes in monolayer conditions by subculturing 3-4 times. A83-01 removal induced senescent cells with high β-galactosidase activity. PDBCCs grown as monolayers were characterized by the majority of cells having an EpCAM+/CD49f + phenotype. Compared to full media in monolayer culture, EGF removal increased EpCAM+/CD49f - phenotype (13.8-fold, p = 0.028), whereas R-spondin removal reduced it (0.8-fold, p = 0.02). A83-01 removal increased EpCAM+/CD24 + phenotype (1.82-fold, p = 0.023) and decreased EpCAM low/-/CD44+/CD24- phenotype (0.45-fold, p = 0.026). Compared to monolayer, spheroid resulted in a significant increase in the population with EpCAM-/CD49+ (14.6-fold, p = 0.006) and EpCAM low/-/CD44+/CD24- phenotypes (4.16-fold, p = 0.022) and ALDH high activity (9.66-fold, p = 0.037). ALDH1A and EMT-related genes were upregulated. In RNA-sequencing analysis between spheroids and monolayers, a total of 561 differentially expressed genes (2-fold change, p < 0.05) were enriched in 27 KEGG pathways including signaling pathways regulating pluripotency of stem cells. In a recurrence-free survival analysis based on the Kaplan-Meier Plotter database of the up-and down-regulated genes identified in spheroids, 15 up-, and 14 down-regulated genes were associated with poor prognosis of breast cancer patients.
The media composition and spheroid culture method change in the BCSCs and EMT markers of PDBCCs, implying the importance of defining the media composition and culture method for studying PDBCCs in vitro.
异质性肿瘤细胞被认为是雌激素受体阳性(ER+)癌症内分泌治疗失败的一个重要因素。培养患者来源的乳腺癌细胞(PDBCCs)为癌症异质性的临床前和转化研究提供了宝贵的工具。本研究旨在探讨不同培养基成分和培养方法对 ER+PDBCCs 中与乳腺癌干细胞(BCSCs)相关的免疫表型和基因表达的影响。
本研究纳入了 10 名 ER+乳腺癌患者,其中 6 名患者接受了新辅助化疗,4 名患者未接受化疗。采用胶原 I 和透明质酸酶酶法分离 PDBCCs。PDBCCs 在含有不同成分的培养基中单层培养,并在悬浮状态下以多细胞球体的形式培养。使用涂有胶原 I 的平板和涂有聚合物-X 的超低附着平板进行单层和球体培养。采用流式细胞术、免疫荧光染色、RT-PCR 和 RNA 测序来检测 PDBCCs 的免疫表型和基因谱。
通过传代培养 3-4 次,超过 95%的 PDBCCs 在单层条件下保持 EpCAM 高/+/成纤维细胞标志物-表型。A83-01 去除诱导具有高β-半乳糖苷酶活性的衰老细胞。在单层培养中,PDBCCs 主要表现为大多数细胞具有 EpCAM+/CD49f+表型。与单层培养中的完全培养基相比,EGF 去除增加了 EpCAM+/CD49f-表型(13.8 倍,p=0.028),而 R-spondin 去除则降低了该表型(0.8 倍,p=0.02)。A83-01 去除增加了 EpCAM+/CD24+表型(1.82 倍,p=0.023),降低了 EpCAM 低/-/CD44+/CD24-表型(0.45 倍,p=0.026)。与单层培养相比,球体培养显著增加了 EpCAM-/CD49+(14.6 倍,p=0.006)和 EpCAM 低/-/CD44+/CD24-表型(4.16 倍,p=0.022)以及 ALDH 高活性(9.66 倍,p=0.037)的细胞群体。ALDH1A 和 EMT 相关基因上调。在球体和单层之间的 RNA 测序分析中,总共鉴定出 561 个差异表达基因(2 倍变化,p<0.05),富集在包括干细胞多能性调控信号通路在内的 27 个 KEGG 通路中。基于 Kaplan-Meier Plotter 数据库中球体中上调和下调基因的无复发生存分析,15 个上调基因和 14 个下调基因与乳腺癌患者的不良预后相关。
培养基成分和球体培养方法改变了 PDBCCs 中的 BCSCs 和 EMT 标志物,这表明定义用于体外研究 PDBCCs 的培养基成分和培养方法非常重要。